Sunday, May 3, 2026

EU Stock Markets Plummet: What’s Behind the 25% Tariff Threat from Trump?

The Greenland dispute triggers sharp declines in European and U.S. stock markets, escalating tensions and potential trade war.

World Radio Day: Celebrating the Timeless Influence of Radio on Education and Society

World Radio Day celebrates radio's role in education and communication, highlighting its evolution from the late 19th century to now.

The Boyz to Host a Live Comeback Event in Celebration of [PHANTASY] Pt.3 Love Letter Release

Male K-POP group, The Boyz, is set...

Tag: Biotech

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Daewoong Pharmaceutical and Primind’s Strategic Investment in American Biotech General Proximity

Daewoong Pharmaceutical invests in biotech firms to enhance drug development using Induced Proximity technology and expand globally.

Cha Biotech Announces Support of K-Bio Startups at Bio Korea 2026

Cha Biotech aims to create a global innovation ecosystem for K-Bio startups through the K-Bio CIC Open Innovation Center.

Korea’s Biotech Healthcare Firms Possess Cutting-edge AI Diagnostics and Precision Medicine

South Korea's biotech sector excels in technology but needs better storytelling and governance to attract global investments.

How the 2026 Drug Price Reform Will Reshape the Pharmaceutical Industry

Experts discuss the impact of drug pricing reform on the pharmaceutical sector, urging innovation and strategic shifts in R&D investments.

Mastering U.S. Patent Risks: Essential Training for Korean Life Sciences Firms

The Korea Pharmaceutical and Bio-Pharma Association will host training on U.S. patent risks for local pharma and biotech professionals.

Revolutionary Male Contraceptive: New Method Halts Sperm Production Without Hormonal Side Effects

A Cornell team developed a reversible male contraceptive, blocking sperm production without hormonal side effects, using a compound called JQ1.

Is VRN110755 the Future of Non-Small Cell Lung Cancer Treatment? Find Out!

Voronoi's VRN110755 for NSCLC receives approval for clinical trial modifications, expanding to a Phase 1b/2 trial across multiple regions.

Celltrion’s Groundbreaking Achievement: First Asian Bio Company to Secure APEC CBPR and Global CBPR Certifications

Celltrion becomes the first South Korean biotech firm to earn APEC CBPR and Global CBPR certifications, enhancing global data protection.

Samsung Biologics Partners with Eli Lilly: How This Open Innovation Hub Will Transform K-Bio by 2027

Samsung Biologics partners with Eli Lilly to create a biotech innovation hub in Korea, enhancing growth opportunities for local firms.

Lotte Biologics at DCAT Week 2026: Unveiling Strategic Collaborations in Global CDMO

Lotte Biologics will attend DCAT Week in New York to pursue global CDMO partnerships and showcase its production capabilities.

South Korea’s Pharmaceutical Future: 500 Million USD Investment from Eli Lilly to Boost K-Bio Innovation

South Korea partners with Eli Lilly to boost biotech and pharma industries, investing $500M to enhance innovation and healthcare access.

Samsung Biologics Joins CEPI: How This Partnership Will Revolutionize Vaccine Production in Asia

Samsung Biologics partners with CEPI to enhance vaccine manufacturing, aiming to strengthen global health security and support local biotech growth.

How SK Bioscience Plans to Dominate the Global Vaccine Market in 2026

SK Bioscience enhances its operational system with new COO and key appointments to boost global competitiveness and vaccine development.

2025’s Drug Price Revolution: What Asian Pharma Firms Need to Know About MFN Policies

Trump's second term sees U.S. drug pricing reforms and supply chain shifts, prompting South Korean firms to seize new opportunities.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.